Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Wild Bioscience is pursuing crop gene editing for higher yields and climate resilience.

Alexander Bedwell
Ross Hendron, CEO and co-founder, Wild Bioscience
Rights and permissions
About this article
Cite this article
Schmidt, C. Editor’s Pick: Wild Bioscience. Nat Biotechnol (2026). https://doi.org/10.1038/s41587-026-03377-w
-
Published:
-
Version of record:
-
DOI: https://doi.org/10.1038/s41587-026-03377-w